Litcius/Paper detail

Adipocyte-derived ferroptotic signaling mitigates obesity

Xue Wang, Qian Wu, Meijuan Zhong, Ying Chen, Y. Wang, Xin Li, Wenxi Zhao, Chaodong Ge, Xinhui Wang, Yingying Yu, Sisi Yang, Tianyi Wang, Enjun Xie, Wanting Shi, Junxia Min, Fudi Wang

2024Cell Metabolism63 citationsDOIOpen Access PDF

Abstract

Ferroptosis is characterized as an iron-dependent and lipophilic form of cell death. However, it remains unclear what role ferroptosis has in adipose tissue function and activity. Here, we find a lower ferroptotic signature in the adipose tissue of individuals and mice with obesity. We further find that activation of ferroptotic signaling by a non-lethal dose of ferroptosis agonists significantly reduces lipid accumulation in primary adipocytes and high-fat diet (HFD)-fed mice. Notably, adipocyte-specific overexpression of acyl-coenzyme A synthetase long-chain family member 4 (Acsl4) or deletion of ferritin heavy chain (Fth) protects mice from HFD-induced adipose expansion and metabolic disorders via activation of ferroptotic signaling. Mechanistically, we find that 5,15-dihydroxyeicosatetraenoic acid (5,15-DiHETE) activates ferroptotic signaling, resulting in the degradation of hypoxia-inducible factor-1α (HIF1α), thereby derepressing a thermogenic program regulated by the c-Myc-peroxisome proliferator-activated receptor gamma coactivator-1 beta (Pgc1β) pathway. Our findings suggest that activating ferroptosis signaling in adipose tissues might help to prevent and treat obesity and its related metabolic disorders.

Topics & Concepts

ObesityAdipocyteSignal transductionMedicineCell biologyBiologyAdipose tissueCancer researchBioinformaticsInternal medicineFerroptosis and cancer prognosisMicroRNA in disease regulationCircular RNAs in diseases
Adipocyte-derived ferroptotic signaling mitigates obesity | Litcius